Leading with the trailing edge: facilitating patient choice for insulin products.

Authors:
Feldman R.

Journal:
J Law Biosci

Publication Year: 2023

DOI:
10.1093/jlb/lsad033

PMCID:
PMC10718803

PMID:
38094183

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Law Biosci

Abbreviation: J Law Biosci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Legal

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Anticipation in the biosciences and the human right to science.
Boggio A. (2024) - Transparency Score: 2/6
CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and …
Pacia DM; Brown BL; Minssen T and 1 more (2024) - Transparency Score: 3/6
Purpose definition as a crucial step for determining the legal basis under the GDPR: implications f…
Becker R; Chokoshvili D; Thorogood A and 5 more (2024) - Transparency Score: 2/6
Cryopreservation and current legal problems: seeking and selling immortality.
Mullock A; Romanis EC. (2023) - Transparency Score: 2/6
Defusing the legal and ethical minefield of epigenetic applications in the military, defense, and s…
Dalpé G; Huerne K; Dupras C and 14 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"This article was supported by a grant from the Commonwealth Fund, beginning in 2021 and ending in 2023. No other external funding supported this project."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025